scispace - formally typeset
D

Daniel P. Ferris

Researcher at University of California, Los Angeles

Publications -  9
Citations -  1779

Daniel P. Ferris is an academic researcher from University of California, Los Angeles. The author has contributed to research in topics: Mesoporous silica & Drug delivery. The author has an hindex of 8, co-authored 9 publications receiving 1648 citations.

Papers
More filters
Journal ArticleDOI

Noninvasive remote-controlled release of drug molecules in vitro using magnetic actuation of mechanized nanoparticles

TL;DR: A novel material that incorporates zinc-doped iron oxide nanocrystals within a mesoporous silica framework that has been surface-modified with pseudorotaxanes is described, which promises to be a noninvasive, externally controlled drug delivery system with cancer-killing properties.
Journal ArticleDOI

Light-Operated Mechanized Nanoparticles

TL;DR: Mesoporous silica nanoparticles modified by azobenzene derivatives, capable of storing small molecules and releasing them following light irradiation, have been fabricated and characterized.
Journal ArticleDOI

Synthesis of Biomolecule-Modified Mesoporous Silica Nanoparticles for Targeted Hydrophobic Drug Delivery to Cancer Cells

TL;DR: These results demonstrate successful biomolecular-targeted hydrophobic drug delivery carriers that selectively target specific cancer cells and result in enhanced drug delivery and cell mortality.
Journal ArticleDOI

Targeted Intracellular Delivery of Antituberculosis Drugs to Mycobacterium tuberculosis-Infected Macrophages via Functionalized Mesoporous Silica Nanoparticles

TL;DR: It is demonstrated that the isoniazid delivered by MSNP equipped with pH-operated nanovalves kill M. tuberculosis within macrophages significantly more effectively than an equivalent amount of free drug.
Journal ArticleDOI

Involvement of lysosomal exocytosis in the excretion of mesoporous silica nanoparticles and enhancement of the drug delivery effect by exocytosis inhibition.

TL;DR: The exocytosis of phosphonate modified mesoporous silica nanoparticles (P-MSNs) is demonstrated and lysosomal exocyTosis is identified as the mechanism responsible for this event.